Workup/Staging Flashcards
What is the most common presenting Sx of bladder cancer?
The most common presenting Sx is painless hematuria.
What are the initial steps in the workup of suspected bladder cancer? What additional workup is needed after a cancer Dx is established?
- Perform cystoscopy and urine cytology.
- If a lesion is identified that is solid or suspicious for muscle invasion, then obtain a CT/MRI of the abdomen and pelvis, ideally prior to Bx so induced inflammatory changes do not result in overstaging.
- Perform an EUA and TURBT.
- If a cancer Dx is made, image the upper urinary tract (CT or MRI urography, intravenous pyelogram, renal US, retrograde pyelogram, or ureteroscopy).
- For muscle-invasive Dz, obtain chest imaging (CXR or CT) and consider a bone scan if the pt is symptomatic or has an elevated alk phos level.
- Recommended blood work includes CBC/CMP.
For adequate clinical staging, what should be present in the initial transurethral resection of bladder tumor (TURBT) pathologic specimen?
The Bx specimen should contain muscle from the bladder wall to properly stage the tumor.
What are the indications for re-resection after initial TURBT?
Repeat resection should be performed when there is:
- Incomplete resection of gross tumor
- High-grade Dz and no muscle in specimen
- Any T1 lesion
What are the AJCC 8th edition (2017) T-stage criteria for bladder cancer?
Ta: noninvasive papillary carcinoma
Tis: CIS (“flat tumor”)
T1: tumor invades lamina propria (subepithelial connective tissue)
T2a: tumor invades superficial muscularis propria (inner half)
T2b: tumor invades deep muscularis propria (outer half)
T3a: microscopic invasion of perivesical tissue
T3b: macroscopic invasion of perivesical tissue
T4a: tumor invades directly into prostatic stroma, seminal vesicles, uterus, vagina
T4b: tumor invades pelvic wall, abdominal wall
Can a TURBT be used to define the pT stage?
No. pT stage is defined by an evaluation of a cystectomy specimen. TURBT findings are included in the clinical T-stage (cT) staging.
What is the probability of pathologic pelvic nodal involvement based on the pT stage of a bladder tumor?
Pelvic node involvement by pT stage (Stein JP et al., JCO 2001):
Overall: 24% LN+
pT0–T1: 5%
pT2: 18%
pT3a: 26%
pT3b: 46%
pT4: 42%
Can the cT stage reliably predict occult pathologic pelvic node involvement?
No. cT stage does not reliably predict occult pathologic node involvement b/c there is significant discordance b/t cT stage and pT stage. (Goldsmith B et al., IJROBP 2014)
What are the AJCC 8th edition (2017) N- and M-stage criteria for bladder cancer?
N0: no regional LN involvement
N1: single +LN in true pelvis (perivesical, obturator, internal and external iliac, or sacral)
N2: multiple regional LNs in true pelvis
N3: mets to common iliac LN
M0: no DMs
M1: DMs
M1a: DMs limited to LNs beyond the common iliacs
M1b: non-LN DMs
Define the AJCC 8th edition (2017) bladder cancer stage grouping based on TNM status.
Stage 0a: Ta, N0, M0
Stage 0is: Tis, N0, M0
Stage I: T1, N0, M0
Stage II: T2a/T2b, N0, M0
Stage IIIA: T3a/T3b/T4a, N0, M0 or T1–T4a, N1, M0
Stage IIIB: T1–T4a, N2/N3, M0
Stage IVA: T4b, Any N, M0 or Any T, Any N, M1a
Stage IVB: Any T, Any N, M1b
Estimate the 5-yr OS by stage.
5-yr OS rates for bladder cancer based on SEER data:
Stage 0: 98%
Stage I: 88%
Stage II: 63%
Stage III: 46%
Stage IV: 15%